HBV viremia in newborns of HBsAg(+) predominantly Caucasian HBeAg(-) mothers

Journal of Clinical Virology

Volumn 50, Issue 3, 2011, Pages 249-252

  Papaevangelou, Vassiliki ^a   Paraskevis, Dimitrios ^a   Anastassiadou, Vassiliki ^a   Stratiki, Evaggelia ^b   Machaira, Maria ^a   Pitsouli, Irene ^a   Haida, Catherine ^a   Drakakis, Petros ^a   Stamouli, Klara ^b   Antsaklis, Aris ^a   Hatzakis, Angelos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

Author keywords

HBV DNA; Hepatitis B virus; In utero transmission; Mother to infant transmission; Neonate; Viral load; Viremia

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; BLOOD SAMPLING; CAUCASIAN; FEMALE; HEPATITIS; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VERTICAL TRANSMISSION;

CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; VIRAL LOAD; VIREMIA;

EID: 79851516373     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.11.009     Document Type: Article

References (30)

1. Evans A.A., London W.T. Epidemiology of hepatitis B. Viral hepatitis 1998, 107-114. Harcourt Brace & Co., Ltd., London, United Kingdom. A.J. Zuckerman, H.C. Thomas (Eds.).
2. American Academy of Pediatrics Hepatitis B. Red book 2009: report of the committee on infectious diseases 2009, 337-356. American Academy of Pediatrics, Elk Grove Village, IL. 28th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
3. Hyams K.C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995, 20:992-1000.
4. Mast E.E., Margolis H.S., Fiore A.E., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1. Immunization of infants, children, and adolescents. MMWR Recomm Rep 2005, 54:1-31.
5. Stevens C.E., Beasley R.P., Tsui J., Lee W.C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975, 292:771-774.
6. Chen H.L., Chang C.J., Kong M.S., et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 2004, 39:58-63.
7. Fawaz K.A., Grady G.F., Kaplan M.M., Gellis S.S. Repetitive maternal-fetal transmission of fatal hepatitis B. N Engl J Med 1975, 293:1357-1359.
8. Friedt M., Gerner P., Lausch E., Trubel H., Zabel B., Wirth S. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 1999, 29:1252-1258.
9. Sterneck M., Kalinina T., Otto S., et al. Neonatal fulminant hepatitis B: structural and functional analysis of complete hepatitis B virus genomes from mother and infant. J Infect Dis 1998, 177:1378-1381.
10. von Weizsacker F., Pult I., Geiss K., Wirth S., Blum H.E. Selective transmission of variant genomes from mother to infant in neonatal fulminant hepatitis B. Hepatology 1995, 21:8-13.
11. Jonas M.M. Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009, 1(29 Suppl):133-139.
12. Soderstrom A., Norkrans G., Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003, 35:814-819.
13. Song Y.M., Sung J., Yang S., Choe Y.H., Chang Y.S., Park W.S. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007, 166:813-818.
14. Xu D.Z., Yan Y.P., Choi B.C., et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002, 67:20-26.
15. Kato H., Nakata K., Hamasaki K., et al. Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction. Vaccine 1999, 18:581-587.
16. Matsumoto T., Nakata K., Hamasaki K., et al. Efficacy of immunization of high-risk infants against hepatitis B virus evaluated by polymerase chain reaction. J Med Virol 1997, 53:255-260.
17. Paraskevis D., Haida C., Tassopoulos N., et al. Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. J Virol Methods 2002, 103:201-212.
18. Paraskevis D., Beloukas A., Haida C., et al. Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA. Virol J 2010, 7:57.
19. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature 1989, 339:237-238.
20. Shi L., Yue Y.F., Zhang S.L., Li S.H., Shi Z.Y., Lei C.M. Peripheral blood mononuclear cell of neonates infected with hepatitis B virus. Zhonghua Er Ke Za Zhi 2006, 44:855-858.
21. Lin H.H., Lee T.Y., Chen D.S., et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987, 111:877-881.
22. Zhang S.L., Yue Y.F., Bai G.Q., Shi L., Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 2004, 10:437-438.
23. Badur S., Lazizi Y., Ugurlu M., et al. Transplacental passage of hepatitis B virus DNA from hepatitis B e antigen-negative mothers and delayed immune response in newborns. J Infect Dis 1994, 169:704-706.
24. Komatsu H., Inui A., Sogo T., et al. Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus. BMC Infect Dis 2010, 10:103.
25. Bai H., Zhang L., Ma L., Dou X.G., Feng G.H., Zhao G.Z. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism. World J Gastroenterol 2007, 13:3625-3630.
26. Beasley R.P., Trepo C., Stevens C.E., Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977, 105:94-98.
27. Okada K., Kamiyama I., Inomata M., Imai M., Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976, 294:746-749.
28. Wang J., Zhu Q., Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J (Engl) 2002, 115:1510-1512.
29. Zhang S.L., Han X.B., Yue Y.F. Relationship between HBV viremia level of pregnant women and intrauterine infection: nested PCR for detection of HBV DNA. World J Gastroenterol 1998, 4:61-63.
30. Koumbi L., Bertoletti A., Anastasiadou V., et al. Hepatitis B specific T helper cell responses in uninfected infants born to HBsAg(+)/HBe(-) mothers. Cell Mol Immunol 2010, [Epub ahead of print].